EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

Paula Díez, Pablo Juanes-Velasco iD, Marina L García-Vaquero, Conrad Droste, Alicia Landeira-Viñuela, Miguel Alcoceba, Helena Fidalgo-Gómez, Sara Misiego-Herrero, Almudena Navarro-Bailón, Mónica Baile, José M Bastida, Jose Manuel Sanchez-Santos und 6 weitere

Molecular Oncology · 2025

DOI: 10.1002/1878-0261.70032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Paula Díez und 17 weiteren Autor:innen. Beteiligte Einrichtung: Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of …. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Receptors, Antigen, B-Cell, Phosphoproteins, Signal Transduction. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Health Institute Carlos III (ISCIII), Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

B‐cell chronic lymphocytic leukemia (B‐CLL) is characterized by highly heterogeneous genomic alterations and altered signaling pathways, with limited studies on its proteome. Our study presents a comprehensive analysis of the proteome and phosphoproteome in B‐CLL and CLL‐like monoclonal B‐cell lymphocytosis (MBL) primary cells. Using high‐resolution mass spectrometry, we identified 2970 proteins and 316 phosphoproteins across five tumor samples, including 55 newly identified phosphopeptides (ProteomeXchange‐PXD005997). Our multifaceted approach also integrated protein microarrays and western blotting for further data validation in a new patient cohort of 14 patients. Despite sharing 73% of their proteomes, the phosphoproteomes varied significantly among samples, independent of cytogenetic alterations and immunoglobulin heavy variable cluster ( IGHV ) mutational status. We identified common functional hallmarks in B‐CLL and MBL phosphoproteomes, notably tonic signaling (low‐level, constitutive signaling) of the B‐cell antigen‐specific receptor (BCR) and nuclear factor NF‐kappa‐B (NF‐kβ)/signal transducer and activator of transcription 3 (STAT3) pathways. Nine phosphoproteins involved in BCR signaling were further validated, showing a high correlation with early disease stages. Our study advances the field by providing a detailed perspective on the proteome and phosphoproteome of B‐CLL cells, revealing signaling pathways crucial for disease development and progression. Integrating diverse proteomics techniques and identifying novel phosphopeptides offers new insights into CLL biology, potentially informing future therapeutic strategies and biomarker development for early diagnosis and personalized treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Lymphocytic, Chronic, B-CellReceptors, Antigen, B-CellPhosphoproteinsSignal TransductionProteomeHumansNeoplasm StagingFemaleMaleProteomics

Stichwörter der Autor:innen

BCR signalingB‐cell chronic lymphocytic leukemiaintracellular protein networkphosphoproteomeproteomicstyrosine kinase

Substanzen

Receptors, Antigen, B-CellPhosphoproteinsProteome

Autor:innen und Institutionen

  • Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca), Spain.
  • Institute of Biomedical Research of Salamanca (IBSAL), Spain.
  • Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
  • Proteomics Unit-IBSAL, Instituto de Investigación Biomédica de Salamanca, Universidad de Salamanca (IBSAL/USAL), Spain.
  • Bioinformatics and Functional Genomics Group, Cancer Research Center (IBMCC, CSIC/USAL), Consejo Superior de Investigaciones Científicas (CSIC) University of Salamanca (USAL), and Instituto de Investigación Biomédica de…
  • Department of Hematology, Cancer Research-Centre IBMCC (CSIC-USAL, IBSAL), University Hospital of Salamanca, CIBERONC-CB16/12/00233, Spain.

ORCID-Profile: Pablo Juanes-Velasco, Javier De Las Rivas, Manuel Fuentes

Förderung

  • Spanish Health Institute Carlos III (ISCIII)
  • Instituto de Salud Carlos III

Zitieren

APA

Díez, P., Juanes-Velasco, P., García-Vaquero, M. L., Droste, C., Landeira-Viñuela, A., Alcoceba, M., Fidalgo-Gómez, H., Misiego-Herrero, S., Navarro-Bailón, A., Baile, M., Bastida, J. M., Sanchez-Santos, J. M., Góngora, R., Almeida, J., Gonzalez-Diaz, M., Orfao, A., De Las Rivas, J., & Fuentes, M. (2025). Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages. Molecular Oncology. https://doi.org/10.1002/1878-0261.70032

Vancouver

Díez P, Juanes-Velasco P, García-Vaquero ML, Droste C, Landeira-Viñuela A, Alcoceba M, et al. Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages. Molecular Oncology. 2025. doi:10.1002/1878-0261.70032

BibTeX
@article{Dez2025,
  author = {Díez, Paula and Juanes-Velasco, Pablo and García-Vaquero, Marina L and Droste, Conrad and Landeira-Viñuela, Alicia and Alcoceba, Miguel and Fidalgo-Gómez, Helena and Misiego-Herrero, Sara and Navarro-Bailón, Almudena and Baile, Mónica and Bastida, José M and Sanchez-Santos, Jose Manuel and Góngora, Rafael and Almeida, Julia and Gonzalez-Diaz, Marcos and Orfao, Alberto and De Las Rivas, Javier and Fuentes, Manuel},
  title = {Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages},
  journal = {Molecular Oncology},
  year = {2025},
  doi = {10.1002/1878-0261.70032}
}
Kostenlos starten →